De-escalation Misses the Mark in Inflammatory Breast Cancer
The trend toward de-escalation in breast cancer treatment may be going too far when it comes to patients with inflammatory disease, according to a US cohort study. While scaling back therapy has been successful for many patients with breast cancer, it hasn …